In melanoma, constitutive activation of MAP Kinase (MAPK) signaling via the RAS-B RAF -MEK-ERK signaling axis has been widely implicated in the initiation and development of cancer due to activation mutations of B-RAF and RAS genes. Here, BRAF is linked to cancer.